Davidson Capital Management Inc. Amgen Inc Transaction History

Davidson Capital Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $1.28 Million - $1.44 Million	-5,683 Reduced 98.73%	73 $16,000
Q2 2022 Aug 17, 2022	SELL	$230.71 - $256.74 $166,341 - $185,109	-721 Reduced 11.13%	5,756 $1.4 Million
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $527,344 - $583,380	2,405 Added 59.06%	6,477 $1.57 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $257,947 - $295,197	-1,297 Reduced 24.16%	4,072 $916,000
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $47,336 - $55,460	223 Added 4.33%	5,369 $1.14 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $93,432 - $103,656	400 Added 8.43%	5,146 $1.25 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $35,727 - $41,634	-161 Reduced 3.28%	4,746 $1.18 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $724,656 - $862,936	3,349 Added 214.96%	4,907 $1.13 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $365,584 - $406,560	1,558 New	1,558 $396,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Davidson Capital Management Inc. with notifications on news.